Covidien, a leading global supplier of healthcare products, announced the acquisition of technology assets from CardioDigital Inc., a company specializing in the development of advanced signal processing techniques for patient monitoring.
Covidien, a leading global supplier of healthcare products, announced the acquisition of technology assets from CardioDigital Inc., a company specializing in the development of advanced signal processing techniques for patient monitoring. The technology, which will be used by Covidien's Respiratory and Monitoring Solutions business unit, reflects the Company's strong commitment to making investments in clinically relevant product innovations designed to improve patient outcomes. Terms of the transaction were not disclosed.
Joe Almeida, President, Medical Devices, Covidien said, The acquisition of CardioDigital's technology is an exciting opportunity for us to strengthen our patient monitoring business as we partner with our customers to improve outcomes. We believe that the technology will enable significant improvements in current patient monitoring techniques, resulting in enhanced patient care and safety.
Almeida said, CardioDigital's innovative technology will complement Respiratory and Monitoring Solution's market-leading Nellcor pulse oximetry platform. In addition, This acquisition sets the stage for more of these types of growth opportunities in the future.
